The cost of multiple drug resistance in Pseudomonas aeruginosa
H Ward, GG Perron, RC Maclean - Journal of evolutionary …, 2009 - academic.oup.com
… Despite the apparent importance of fitness costs in the evolution of drug resistance, few …
This study demonstrates that the evolution of MDR from single drug resistance in P. aeruginosa …
This study demonstrates that the evolution of MDR from single drug resistance in P. aeruginosa …
Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections
… of multidrug-resistant or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has
… This article reviews their mechanisms of resistance, epidemiology, and clinical impact and …
… This article reviews their mechanisms of resistance, epidemiology, and clinical impact and …
Pseudomonas aeruginosa: Multi-drug-resistance development and treatment options
G Meletis, M Bagkeri - Infection Control, 2013 - books.google.com
… Isolations in some countries of multi-drug-resistant (resistant to three or more classes of …
-drug-resistant (resistant to all but one or two classes) or even pan-drugresistant (resistant to all …
-drug-resistant (resistant to all but one or two classes) or even pan-drugresistant (resistant to all …
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
C Liao, X Huang, Q Wang, D Yao, W Lu - Frontiers in cellular and …, 2022 - frontiersin.org
… antibiotic therapy, as the former imposes minimal selective pressure on P. aeruginosa, thus
less likely to induce drug resistance. In this review, we will discuss the virulence factors of P. …
less likely to induce drug resistance. In this review, we will discuss the virulence factors of P. …
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa
N Masuda, E Sakagawa, S Ohya - Antimicrobial agents and …, 1995 - Am Soc Microbiol
… -drug-resistant mutants showing different resistance spectra and … Resistance of Pseudomonas
aeruginosa PAO to nalidixic … of ciproffoxacin resistance in Pseudomonas aeruginosa PAO…
aeruginosa PAO to nalidixic … of ciproffoxacin resistance in Pseudomonas aeruginosa PAO…
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature
ME Falagas, P Kopterides - Journal of Hospital Infection, 2006 - Elsevier
… methods of DNA fingerprinting have shown that the development of multi-drug resistance
may occur by both acquisition of drug resistance by existing strains and by cross-infection with …
may occur by both acquisition of drug resistance by existing strains and by cross-infection with …
Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance in Pseudomonas aeruginosa
A Dötsch, T Becker, C Pommerenke… - Antimicrobial agents …, 2009 - Am Soc Microbiol
… drug resistance, especially for problematic gram-negative bacteria such as Pseudomonas
aeruginosa. … mechanisms of intrinsic resistance, as well as the potential to mutate, gaining …
aeruginosa. … mechanisms of intrinsic resistance, as well as the potential to mutate, gaining …
Severe Pseudomonas aeruginosa infections: Tackling the conundrum of drug resistance
AR Hauser, P Sriram - Postgraduate medicine, 2005 - Taylor & Francis
… these must be considered when choosing an antibiotic regimen for patients infected with
P aeruginosa. Intrinsic resistance In gener~l, P aeruginosa is naturally less susceptible than …
P aeruginosa. Intrinsic resistance In gener~l, P aeruginosa is naturally less susceptible than …
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
B Cao, H Wang, H Sun, Y Zhu, M Chen - Journal of Hospital Infection, 2004 - Elsevier
Risk factors for multi-drug resistant Pseudomonas aeruginosa (MDRP) infections were
investigated using a case–control study design involving MDRP patients (N=44) and controls (N=…
investigated using a case–control study design involving MDRP patients (N=44) and controls (N=…
Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition
… aeruginosa positive cultures. Their … % non-resistant, 29.6% resistant and 33.3% multi-drug
resistant. The total mean economic cost per admission of patients with multi-drug resistant P. …
resistant. The total mean economic cost per admission of patients with multi-drug resistant P. …
相关搜索
- pseudomonas aeruginosa drug selection
- pseudomonas aeruginosa infections
- pseudomonas aeruginosa antibiotic resistance
- pseudomonas aeruginosa acinetobacter baumannii
- pseudomonas aeruginosa rifampicin resistance
- pseudomonas aeruginosa antimicrobial resistance
- multiple drug resistance in pseudomonas aeruginosa
- pseudomonas aeruginosa intrinsic resistance
- pseudomonas aeruginosa membrane protein
- pseudomonas aeruginosa fitness effects
- pseudomonas aeruginosa fitness cost
- pseudomonas aeruginosa acquisition
- pseudomonas aeruginosa risk factors
- carbapenem resistant pseudomonas aeruginosa
- ciprofloxacin consumption resistant pseudomonas aeruginosa
- pseudomonas aeruginosa implications for therapy